US20110070227A1
(en)
*
|
2009-09-18 |
2011-03-24 |
Anna-Marie Novotney-Barry |
Treatment of Autoimmune and Inflammatory Diseases
|
NZ701040A
(en)
*
|
2012-07-04 |
2017-02-24 |
Hoffmann La Roche |
Covalently linked antigen-antibody conjugates
|
EA201590174A1
(en)
*
|
2012-07-09 |
2015-09-30 |
Дженентек, Инк. |
IMMUNOCONGATES CONTAINING ANTI-CD22 ANTIBODIES
|
AU2013288932A1
(en)
*
|
2012-07-09 |
2014-12-11 |
Genentech, Inc. |
Immunoconjugates comprising anti - CD79b antibodies
|
CA2874904A1
(en)
*
|
2012-07-09 |
2014-01-16 |
Genentech, Inc. |
Immunoconjugates comprising anti-cd22 antibodies
|
RU2664465C2
(en)
*
|
2012-10-11 |
2018-08-17 |
Дайити Санкио Компани, Лимитед |
Antibody-drug conjugate
|
JP6272230B2
(en)
|
2012-10-19 |
2018-01-31 |
第一三共株式会社 |
Antibody-drug conjugate conjugated with a linker containing a hydrophilic structure
|
CN105007937B
(en)
*
|
2012-12-20 |
2019-11-19 |
米迪缪尼有限公司 |
Methods of producing immunoconjugates
|
CN105283201B
(en)
*
|
2013-03-14 |
2019-08-02 |
斯克利普斯研究所 |
Targeting agent antibody coupling matter and application thereof
|
FR3008408B1
(en)
|
2013-07-11 |
2018-03-09 |
Mc Saf |
NOVEL ANTIBODY-MEDICAMENT CONJUGATES AND THEIR USE IN THERAPY
|
KR102237803B1
(en)
|
2013-12-25 |
2021-04-09 |
다이이찌 산쿄 가부시키가이샤 |
Anti-trop2 antibody-drug conjugate
|
ES3005311T3
(en)
|
2014-01-31 |
2025-03-14 |
Daiichi Sankyo Co Ltd |
Anti-her2 antibody-drug conjugate
|
IL300540B2
(en)
|
2014-04-10 |
2024-08-01 |
Daiichi Sankyo Co Ltd |
Method for producing an anti-her3 antibody-drug conjugate
|
ES2754348T3
(en)
|
2014-04-10 |
2020-04-17 |
Daiichi Sankyo Co Ltd |
Conjugate of (anti-HER2 antibody) -pharmaceutical
|
SG11201610624WA
(en)
*
|
2014-06-20 |
2017-01-27 |
Bioalliance Cv |
Anti-cd22 antibody-drug conjugates and methods of using thereof
|
JP6618539B2
(en)
*
|
2014-12-17 |
2019-12-11 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Method for enzyme-mediated polypeptide conjugation using sortase
|
WO2016096787A1
(en)
*
|
2014-12-17 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Enzymatic one-pot reaction for double polypeptide conjugation in a single step using sortase
|
KR20180021723A
(en)
|
2015-06-29 |
2018-03-05 |
다이이찌 산쿄 가부시키가이샤 |
Method for selectively manufacturing antibody-drug conjugate
|
CN106467575B
(en)
*
|
2015-08-18 |
2020-07-31 |
四川百利药业有限责任公司 |
Cysteine engineered antibody-toxin conjugates
|
EP3165237B1
(en)
*
|
2015-11-03 |
2018-12-19 |
Industrial Technology Research Institute |
Antibody-drug conjugate (adc) and method for forming the same
|
MX2018005785A
(en)
*
|
2015-11-09 |
2019-04-04 |
Scherer Technologies Llc R P |
Anti-cd22 antibody-maytansine conjugates and methods of use thereof.
|
TWI780104B
(en)
|
2017-01-17 |
2022-10-11 |
日商第一三共股份有限公司 |
Anti gpr20 antibodies and anti gpr20 antibody-drug conjugates, as well as manufacturing method and use thereof
|
CN108452318B
(en)
*
|
2017-02-17 |
2023-05-26 |
浙江特瑞思药业股份有限公司 |
CD 20-targeted antibody coupling drug as well as preparation method and application thereof
|
TWI855528B
(en)
|
2017-05-15 |
2024-09-11 |
日商第一三共股份有限公司 |
Manufacturing method of antibody-drug conjugates
|
CA3074208C
(en)
|
2017-08-31 |
2023-10-03 |
Daiichi Sankyo Company, Limited |
Novel method for producing antibody-drug conjugate
|
WO2019044947A1
(en)
|
2017-08-31 |
2019-03-07 |
第一三共株式会社 |
Improved method for producing antibody-drug conjugate
|
JP2021501198A
(en)
*
|
2017-10-27 |
2021-01-14 |
トランスフュージョン ヘルス,リミティド ライアビリティ カンパニー |
Compositions and Methods for Proliferating Hematopoietic Stem Cells Using Fluorene Derivatives
|
NZ764948A
(en)
*
|
2017-11-30 |
2024-08-30 |
Ladrx Corp |
Albumin-binding prodrugs of auristatin e derivatives
|
CN108727499B
(en)
*
|
2018-04-24 |
2021-12-31 |
四川百利药业有限责任公司 |
Cysteine engineered antibody-toxin conjugates
|
WO2019219889A1
(en)
|
2018-05-18 |
2019-11-21 |
Glycotope Gmbh |
Anti-muc1 antibody
|
AU2019315177A1
(en)
|
2018-07-31 |
2021-02-25 |
Daiichi Sankyo Company, Limited |
Treatment of metastatic brain tumor by administration of antibody-drug conjugate
|
CN109824759A
(en)
*
|
2019-03-08 |
2019-05-31 |
联宁(苏州)生物制药有限公司 |
A kind of Preparation Method And Their Intermediate of the drug-linker MC-MMAF for antibody drug conjugates
|
MX2022015695A
(en)
*
|
2020-06-08 |
2023-03-21 |
Baili Bio Chengdu Pharmaceutical Co Ltd |
Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof.
|
CN112924665B
(en)
*
|
2021-02-19 |
2023-10-03 |
山东莱博生物科技有限公司 |
Antibody horseradish peroxidase marker and preparation and application thereof
|